← Back to Influence Map
Entity DossierOrganization
NOVO NORDISK, INC.
DC · US
Pharmaceutical company
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$9,220,000
Connections
17
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$17.0MMMMMedicare/Medicaid
$15.2MBUDBudget/Appropriations
$12.6MCPTCopyright/Patent/Trademark
$10.5MTAXTaxation/Internal Revenue Code
$6.0MTARTariff
$4.7MPHAPharmacy
$1.2MTRDTrade
$440KCSPConsumer Protection
$220KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$9.7M
NVG, LLC$1.2M
WILLIAMS AND JENSEN, PLLC$840K
TARPLIN, DOWNS & YOUNG, LLC$840K
HOLLAND & KNIGHT LLP$730K
ARNOLD & PORTER KAYE SCHOLER LLP$720K
TODD STRATEGY GROUP$690K
THE MADISON GROUP$690K
AVOQ, LLC$640K
CHECKMATE GOVERNMENT RELATIONS$540K
Ballard Partners$520K
THE NICKLES GROUP, LLC$480K
Public Strategies Washington$370K
S-3 GROUP$40K
E3 STRATEGIC CONSULTING GROUP$0
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied on | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $80,000 | Source |
| Retained | CHECKMATE GOVERNMENT RELATIONS | Hired CHECKMATE GOVERNMENT RELATIONS to lobby on Pharmaceuticals | Source |
| Retained | Arnold & Porter Kaye Scholer | Hired ARNOLD & PORTER KAYE SCHOLER LLP to lobby on Insulin Price Caps | Source |
| Retained | ARNOLD & PORTER KAYE SCHOLER LLP | Hired ARNOLD & PORTER KAYE SCHOLER LLP to lobby on Insulin Price Caps | Source |
| Retained | NVG, LLC | Hired NVG, LLC to lobby on Insulin Price Caps | Source |
| Retained | Public Strategies Washington | Hired PUBLIC STRATEGIES WASHINGTON, INC. to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | HOLLAND & KNIGHT LLP | Hired HOLLAND & KNIGHT LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | WILLIAMS AND JENSEN, PLLC | Hired WILLIAMS AND JENSEN, PLLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | AVOQ, LLC | Hired AVOQ, LLC to lobby (2nd Quarter (Apr 1 - June 30) 2023) | Source |
| Retained | THE MADISON GROUP | Hired THE MADISON GROUP to lobby (3rd Quarter (July 1 - Sep 30) 2023) | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (3rd Quarter (July 1 - Sep 30) 2023) | Source |
| Retained | E3 STRATEGIC CONSULTING GROUP | Hired E3 STRATEGIC CONSULTING GROUP to lobby (3rd Quarter (July 1 - Sep 30) 2024) | Source |
| Retained | THE NICKLES GROUP, LLC | Hired THE NICKLES GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Retained | Ballard Partners | Hired BALLARD PARTNERS to lobby (2nd Quarter (Apr 1 - June 30) 2025) | Source |
| Retained | S-3 GROUP | Hired S-3 GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2026) | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,180,000 | Source |